Mark Goldsmith

Chairman and CEO

Chairman CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$812,500	—	$3,968,076	$8,995,114	$889,700	$7,000	$14,672,390
2024	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$689,167	—	$2,682,000	$6,049,524	$651,800	$7,000	$10,079,491
2023	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$631,121	—	$2,756,000	$6,540,026	$477,100	$7,000	$10,411,247
2022	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$606,667	—	$1,930,240	$4,234,032	$439,900	$7,000	$7,217,839
2021	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$580,833	—	$2,037,600	$4,785,184	$418,300	$7,000	$7,828,917
2020	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$554,011	—	—	$1,426,200	$406,000	$2,000	$2,388,211
2019	Revolution Medicines, Inc. (RVMD)	M.D., Ph.D. President and Chief Executive Officer	$504,300	—	—	$3,808,974	$260,980	$2,000	$4,576,254

Earnings-call appearances

Revolution Medicines, Inc. Q2 FY2026 Earnings Call
Revolution Medicines, Inc. (RVMD)

2026-08-05
Revolution Medicines Conference Call
Revolution Medicines, Inc. (RVMD)

2026-05-31
Revolution Medicines, Inc. Q1 FY2026 Earnings Call
Revolution Medicines, Inc. (RVMD)

2026-05-06
Revolution Medicines, Inc. Q4 FY2025 Earnings Call
Revolution Medicines, Inc. (RVMD)

2026-02-25
Revolution Medicines, Inc. Q3 FY2025 Earnings Call
Revolution Medicines, Inc. (RVMD)

2025-11-05
Revolution Medicines, Inc. Q2 FY2025 Earnings Call
Revolution Medicines, Inc. (RVMD)

2025-08-06
Revolution Medicines, Inc. Q1 FY2025 Earnings Call
Revolution Medicines, Inc. (RVMD)

2025-05-07
Revolution Medicines, Inc. Q4 FY2024 Earnings Call
Revolution Medicines, Inc. (RVMD)

2025-02-26
Revolution Medicines, Inc. Q3 FY2024 Earnings Call
Revolution Medicines, Inc. (RVMD)

2024-11-06
Revolution Medicines, Inc. Q2 FY2024 Earnings Call
Revolution Medicines, Inc. (RVMD)

2024-08-07
Revolution Medicines, Inc. Q1 FY2024 Earnings Call
Revolution Medicines, Inc. (RVMD)

2024-05-08
Revolution Medicines, Inc. Q4 FY2023 Earnings Call
Revolution Medicines, Inc. (RVMD)

2024-02-26
Revolution Medicines, Inc. Q3 FY2023 Earnings Call
Revolution Medicines, Inc. (RVMD)

2023-11-06
Revolution Medicines, Inc. Q2 FY2023 Earnings Call
Revolution Medicines, Inc. (RVMD)

2023-08-08
Revolution Medicines, Inc. Q1 FY2023 Earnings Call
Revolution Medicines, Inc. (RVMD)

2023-05-08
Revolution Medicines, Inc. Q4 FY2022 Earnings Call
Revolution Medicines, Inc. (RVMD)

2023-02-27
Revolution Medicines, Inc. Q3 FY2022 Earnings Call
Revolution Medicines, Inc. (RVMD)

2022-11-07
Revolution Medicines, Inc. Q2 FY2022 Earnings Call
Revolution Medicines, Inc. (RVMD)

2022-08-09
Revolution Medicines, Inc. Q1 FY2022 Earnings Call
Revolution Medicines, Inc. (RVMD)

2022-05-09
Revolution Medicines, Inc. Q4 FY2021 Earnings Call
Revolution Medicines, Inc. (RVMD)

2022-01-11
Revolution Medicines, Inc. Q3 FY2021 Earnings Call
Revolution Medicines, Inc. (RVMD)

2021-11-10